Mitochondrial thiols in the regulation of cell death pathways

Antioxidants and Redox Signaling

Volumn 17, Issue 12, 2012, Pages 1714-1727

  Yin, Fei ^a   Sancheti, Harsh ^a   Cadenas, Enrique ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAREDOXIN; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; ISOCITRATE DEHYDROGENASE 2; METHIONINE SULFOXIDE REDUCTASE; MITOCHONDRIAL PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) TRANSHYDROGENASE; PEROXIREDOXIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; THIOL DERIVATIVE;

CELL DEATH; CELL GROWTH; CELL SURVIVAL; CHEMICAL REACTION; ELECTRON TRANSPORT; ENZYME ACTIVITY; GLUTATHIONYLATION; HOMEOSTASIS; HUMAN; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; REGULATORY MECHANISM; RESPIRATORY CHAIN; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CELL DEATH; GLUTATHIONE PEROXIDASE; HUMANS; METHIONINE SULFOXIDE REDUCTASES; MITOCHONDRIA; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIREDOXINS; SIGNAL TRANSDUCTION; SULFHYDRYL COMPOUNDS;

EID: 84867725042     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4639     Document Type: Review

References (205)

1. Abbas K, Breton J, Planson AG, Bouton C, Bignon J, Seguin C, Riquier S, Toledano MB, and Drapier JC. Nitric oxide activates an Nrf2/sulfiredoxin antioxidant pathway in macrophages. Free Radic Biol Med 51: 107-114, 2011..
2. Andersen JK. Oxidative stress in neurodegeneration: Cause or consequence? Nat Med 10: S18-25, 2004..
3. Anderson MF, Nilsson M, and Sims NR. Glutathione monoethylester prevents mitochondrial glutathione depletion during focal cerebral ischemia. Neurochem Int 44: 153-159, 2004.. (Pubitemid 37249433)
4. Anderson MF and Sims NR. The effects of focal ischemia and reperfusion on the glutathione content of mitochondria from rat brain subregions. J. Neurochem 81: 541-549, 2002.. (Pubitemid 34809332)
5. 2 gradients across biomembranes. FEBS Lett 475: 121-126, 2000.. (Pubitemid 30365063)
6. 2 induce apoptosis through Fenton chemistry independent of the cellular thiol state. Free Radic Biol Med 30: 1008-1018, 2001.. (Pubitemid 32333031)
7. Araki M, Nanri H, Ejima K, Murasato Y, Fujiwara T, Na-kashima Y, and Ikeda M. Antioxidant function of the mi-tochondrial protein SP-22 in the cardiovascular system. J Biol Chem 274: 2271-2278, 1999..
8. Aslund F and Beckwith J. Bridge over troubled waters: sensing stress by disulfide bond formation. Cell 96: 751-3, 1999.. (Pubitemid 29165077)
9. Bae SH, Sung SH, Cho EJ, Lee SK, Lee HE, Woo HA, Yu DY, Kil IS, and Rhee SG. Concerted action of sulfiredoxin and peroxiredoxin I protects against alcohol-induced oxi-dative injury in mouse liver. Hepatology 53: 945-953, 2011..
10. Bae SH, Woo HA, Sung SH, Lee HE, Lee SK, Kil IS, and Rhee SG. Induction of sulfiredoxin via an Nrf2-dependent pathway and hyperoxidation of peroxiredoxin III in the lungs of mice exposed to hyperoxia. Antioxid Redox Signal 11: 937-948, 2009..
11. Banmeyer I, Marchand C, Clippe A, and Knoops B. Human mitochondrial peroxiredoxin 5 protects from mitochondrial DNA damages induced by hydrogen peroxide. FEBS Lett 579: 2327-2333, 2005.. (Pubitemid 40569500)
12. Banmeyer I, Marchand C, Verhaeghe C, Vucic B, Rees JF, and Knoops B. Overexpression of human peroxiredoxin 5 in subcellular compartments of Chinese hamster ovary cells: Effects on cytotoxicity and DNA damage caused by peroxides. Free Radic Biol Med 36: 65-077, 2004..
13. Barnham KJ, Masters CL, and Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3: 205-214, 2004..
14. Beal MF. Aging, energy, and oxidative stress in neurode-generative diseases. Ann Neurol 38: 357-366, 1995..
15. Beer SM, Taylor ER, Brown SE, Dahm CC, Costa NJ, Runswick MJ, and Murphy MP. Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mito-chondrial membrane thiol proteins: Implications for mito-chondrial redox regulation and antioxidant defense. J Biol Chem 279: 47939-47951, 2004.. (Pubitemid 39540945)
16. Boyd-Kimball D, Sultana R, Abdul HM, and Butterfield DA. Gamma-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against Abeta(1-42)-medi-ated oxidative stress and neurotoxicity: Implications for Alzheimer's disease. J Neurosci Res 79: 700-706, 2005.. (Pubitemid 40476449)
17. Bruguera M, Bertran A, Bombi JA, and Rodes J. Giant mitochondria in hepatocytes: A diagnostic hint for alcoholic liver disease. Gastroenterology 73: 1383-1387, 1977.. (Pubitemid 8229294)
18. Chae HZ, Kim HJ, Kang SW, and Rhee SG. Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res Clin Pract 45: 101-112, 1999.. (Pubitemid 29457756)
19. Chang TS, Cho CS, Park S, Yu S, Kang SW, and Rhee SG. Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. J Biol Chem 279: 41975-41984, 2004.. (Pubitemid 39313648)
20. Chang TS, Jeong W, Woo HA, Lee SM, Park S, and Rhee SG. Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cyste-ine. J Biol Chem 279: 50994-51001, 2004.. (Pubitemid 40017840)
21. 2 by overexpressing peroxiredoxin 3 improves glucose tolerance in mice. Aging Cell 7: 866-878, 2008.. (Pubitemid 352749440)
22. Chen Y, Cai J, and Jones DP. Mitochondrial thioredoxin in regulation of oxidant-induced cell death. FEBS Lett 580: 6596-6602, 2006.. (Pubitemid 44830129)
23. Chen Y, Cai J, Murphy TJ, and Jones DP. Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells. J Biol Chem 277: 33242-33248, 2002.. (Pubitemid 34984844)
24. Chen YR, Chen CL, Pfeiffer DR, and Zweier JL. Mi-tochondrial complex II in the post-ischemic heart: Oxida-tive injury and the role of protein S-glutathionylation. J Biol Chem 282: 32640-32654, 2007.. (Pubitemid 350159288)
25. Chen Z and Lash LH. Evidence for mitochondrial uptake of glutathione by dicarboxylate and 2-oxoglutarate carriers. J Pharmacol Exp Ther 285: 608-618, 1998.. (Pubitemid 28237440)
26. Chen Z, Putt DA, and Lash LH. Enrichment and functional reconstitution of glutathione transport activity from rabbit kidney mitochondria: Further evidence for the role of the dicarboxylate and 2-oxoglutarate carriers in mitochondrial glutathione transport. Arch Biochem Biophys 373: 193-202, 2000.. (Pubitemid 30046504)
27. Chinta SJ and Andersen JK. Reversible inhibition of mito-chondrial complex I activity following chronic dopami-nergic glutathione depletion in vitro: Implications for Parkinson's disease. Free Radic Biol Med 41: 1442-1448, 2006.. (Pubitemid 44466728)
28. Chiribau CB, Cheng L, Cucoranu IC, Yu YS, Clempus RE, and Sorescu D. FOXO3A regulates peroxiredoxin III expression in human cardiac fibroblasts. J Biol Chem 283: 8211-8217, 2008..
29. Choi JH, Kim TN, Kim S, Baek SH, Kim JH, Lee SR, and Kim Jr. Overexpression of mitochondrial thioredoxin re-ductase and peroxiredoxin III in hepatocellular carcinomas. Anticancer Res 22: 3331-3335, 2002.. (Pubitemid 36070110)
30. Chrestensen CA, Starke DW, and Mieyal JJ. Acute cadmium exposure inactivates thioltransferase (glutaredoxin), inhibits intracellular reduction of protein-glutathionyl-mixed disulfides, and initiates apoptosis. J Biol Chem 275: 26556-26565, 2000..
31. Chung YM, Yoo YD, Park JK, Kim YT, and Kim HJ. Increased expression of peroxiredoxin II confers resistance to cisplatin. Anticancer Res 21: 1129-1133, 2001..
32. Colell A, Garcia-Ruiz C, Miranda M, Ardite E, Mari M, Morales A, Corrales F, Kaplowitz N, and Fernandez-Checa JC. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor. Gastroenterology 115: 1541-1551, 1998.. (Pubitemid 28546006)
33. Coll O, Colell A, Garcia-Ruiz C, Kaplowitz N, and Fer-nandez-Checa JC. Sensitivity of the 2-oxoglutarate carrier to alcohol intake contributes to mitochondrial glutathione depletion. Hepatology 38: 692-702, 2003.. (Pubitemid 37052156)
34. Costa NJ, Dahm CC, Hurrell F, Taylor ER, and Murphy MP. Interactions of mitochondrial thiols with nitric oxide. Antioxid Redox Signal 5: 291-305, 2003.. (Pubitemid 36793013)
35. Cox AG, Pearson AG, Pullar JM, Jonsson TJ, Lowther WT, Winterbourn CC, and Hampton MB. Mitochondrial per-oxiredoxin 3 is more resilient to hyperoxidation than cy-toplasmic peroxiredoxins. Biochem J 421: 51-58, 2009..
36. Cox AG, Peskin AV, Paton LN, Winterbourn CC, and Hampton MB. Redox potential and peroxide reactivity of human peroxiredoxin 3. Biochemistry 48: 6495-6501, 2009..
37. Cox AG, Pullar JM, Hughes G, Ledgerwood EC, and Hampton MB. Oxidation of mitochondrial peroxiredoxin 3 during the initiation of receptor-mediated apoptosis. Free Radic Biol Med 44: 1001-1009, 2008..
38. Cox AG, Winterbourn CC, and Hampton MB. Mitochon-drial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem J 425: 313-325, 2010..
39. Cunningham CC and Bailey SM. Ethanol consumption and liver mitochondria function. Neurosignals 10: 271-282, 2001.. (Pubitemid 32449005)
40. Dalle-Donne I, Colombo G, Gagliano N, Colombo R, Giustarini D, Rossi R, and Milzani A. S-glutathiolation in life and death decisions of the cell. Free Radic Res. 45: 3-15, 2011..
41. Dalle-Donne I, Milzani A, Gagliano N, Colombo R, Gius-tarini D, and Rossi R. Molecular mechanisms and potential clinical significance of S-glutathionylation. Antioxid. Redox Signal 10: 445-473, 2008..
42. Damdimopoulos AE, Miranda-Vizuete A, Pelto-Huikko M, Gustafsson JA, and Spyrou G. Human mitochondrial thioredoxin. Involvement in mitochondrial membrane potential and cell death. J Biol Chem 277: 33249-33257, 2002.. (Pubitemid 34984845)
43. de la Asuncion J, Millan A, Pla R, Bruseghini L, Esteras A, Pallardo F, Sastre J, and Vina J. Mitochondrial glutathione oxidation correlates with age-associated oxidative damage to mitochondrial DNA. FASEB J 10: 333-338, 1996.. (Pubitemid 26079953)
44. +. Neurosci Lett 433: 219-224, 2008..
45. Deneke SM and Fanburg BL. Regulation of cellular gluta-thione. Am J Physiol. 257: L163-L173, 1989..
46. Dubuisson M, Vander Stricht D, Clippe A, Etienne F, Nauser T, Kissner R, Koppenol WH, Rees JF, and Knoops B. Human peroxiredoxin 5 is a peroxynitrite reductase. FEBS Lett 571: 161-165, 2004.. (Pubitemid 38992941)
47. Ehrhart J, Gluck M, Mieyal J, and Zeevalk GD. Functional glutaredoxin (thioltransferase) activity in rat brain and liver mitochondria. Parkinsonism Relat Disord 8: 395-400, 2002.. (Pubitemid 36157326)
48. Enoksson M, Fernandes AP, Prast S, Lillig CH, Holmgren A, and Orrenius S. Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c release. Biochem Biophys Res Commun 327: 774-779, 2005.. (Pubitemid 40092816)
49. Fernandes RS and Cotter TG. Apoptosis or necrosis: In-tracellular levels of glutathione influence mode of cell death. Biochem Pharmacol 48: 675-681, 1994.. (Pubitemid 24283836)
50. Fernandez-Checa JC, Garcia-Ruiz C, Ookhtens M, and Kaplowitz N. Impaired uptake of glutathione by hepatic mitochondria from chronic ethanol-fed rats. Tracer kinetic studies in vitro and in vivo and susceptibility to oxidant stress. J Clin Invest 87: 397-405, 1991..
51. Garcia J, Han D, Sancheti H, Yap LP, Kaplowitz N, and Cadenas E. Regulation of mitochondrial glutathione redox status and protein glutathionylation by respiratory substrates. J Biol Chem 285: 39646-39654, 2010..
52. Gladyshev VN, Liu A, Novoselov SV, Krysan K, Sun QA, Kryukov VM, Kryukov GV, and Lou MF. Identification and characterization of a new mammalian glutaredoxin (thioltransferase), Grx2. J Biol Chem 276: 30374-30380, 2001..
53. Glauser DA, Brun T, Gauthier BR, and Schlegel W. Transcriptional response of pancreatic beta cells to metabolic stimulation: Large scale identification of immediate-early and secondary response genes. BMC Mol Biol 8: 54, 2007..
54. Griffith OW and Meister A. Origin and turnover of mito-chondrial glutathione. Proc Natl Acad Sci USA 82: 4668-4672, 1985..
55. Gu M, Owen AD, Toffa SE, Cooper JM, Dexter DT, Jenner P, Marsden CD, and Schapira AH. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases. J Neurol Sci 158: 24-29, 1998.. (Pubitemid 28277530)
56. Han D, Canali R, Garcia J, Aguilera R, Gallaher TK, and Cadenas E. Sites and mechanisms of aconitase inactivation by peroxynitrite: Modulation by citrate and glutathione. Biochemistry 44: 11986-11996, 2005.. (Pubitemid 41285696)
57. Hansen JM, Go YM, and Jones DP. Nuclear and mito-chondrial compartmentation of oxidative stress and re-dox signaling. Annu Rev Pharmacol Toxicol 46: 215-234, 2006.. (Pubitemid 43271189)
58. Hansen JM, Zhang H, and Jones DP. Mitochondrial thior-edoxin-2 has a key role in determining tumor necrosis factor-alpha-induced reactive oxygen species generation, NF-kappaB activation, and apoptosis. Toxicol Sci 91: 643-650, 2006.. (Pubitemid 43827316)
59. Hattori F, Murayama N, Noshita T, and Oikawa S. Mi-tochondrial peroxiredoxin-3 protects hippocampal neurons from excitotoxic injury in vivo. J Neurochem 86: 860-868, 2003.. (Pubitemid 36988798)
60. He M, Cai J, Go YM, Johnson JM, Martin WD, Hansen JM, Jones DP. Identification of thioredoxin-2 as a regulator of the mitochondrial permeability transition. Toxicol Sci 105: 44-50, 2008..
61. Hill BG and Darley-Usmar VM. S-nitrosation and thiol switching in the mitochondrion: A new paradigm for cardioprotection in ischaemic preconditioning. Biochem J 412: e11-13, 2008..
62. Hill BG, Higdon AN, Dranka BP, and Darley-Usmar VM. Regulation of vascular smooth muscle cell bioenergetic function by protein glutathiolation. Biochim Biophys Acta. 1797: 285-295, 2010..
63. Hoek JB and Rydström J. Physiological roles of nicotin-amide nucleotide transhydrogenase. Biochem J 254: 1-10, 1988
64. Hofmann B, Hecht HJ, and Flohe L. Peroxiredoxins. Biol Chem 383: 347-364, 2002.. (Pubitemid 34506276)
65. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 264: 13963-13966, 1989.. (Pubitemid 19214215)
66. Holmgren A and Aslund F. Glutaredoxin. Methods Enzymol 252: 283-292, 1995..
67. Holmgren A, Johansson C, Berndt C, Lonn ME, Hudemann C, and Lillig CH. Thiol redox control via thioredoxin and glutaredoxin systems. Biochem Soc Trans 33: 1375-1377, 2005.. (Pubitemid 41779691)
68. Huang J and Philbert MA. Cellular responses of cultured cerebellar astrocytes to ethacrynic acid-induced perturbation of subcellular glutathione homeostasis. Brain Res 711: 184-192, 1996.. (Pubitemid 26080241)
69. Hurd TR, Costa NJ, Dahm CC, Beer SM, Brown SE, Fili-povska A, and Murphy MP. Glutathionylation of mito-chondrial proteins. Antioxid Redox Signal 7: 999-1010, 2005..
70. Hwang C, Sinskey A, and Lodish H. Oxidized redox state of glutathione in the endoplasmic reticulum. Science 257: 1496-1502, 1992..
71. Imberti R, Nieminen AL, Herman B, and Lemasters JJ. Mitochondrial and glycolytic dysfunction in lethal injury to hepatocytes by t-butylhydroperoxide: Protection by fructose, cyclosporin A and trifluoperazine. J Pharmacol Exp Ther 265: 392-400, 1993.. (Pubitemid 23320987)
72. Immenschuh S and Baumgart-Vogt E. Peroxiredoxins, ox-idative stress, and cell proliferation. Antioxid Redox Signal 7: 768-777, 2005.. (Pubitemid 40563217)
73. Jeong W, Park SJ, Chang TS, Lee DY, and Rhee SG. Molecular mechanism of the reduction of cysteine sulfinic acid of peroxiredoxin to cysteine by mammalian sulfiredoxin. J Biol Chem 281: 14400-14407, 2006.. (Pubitemid 43848370)
74. Jia Z, Zhu H, Misra B, Li Y, and Misra H. Dopamine as a potent inducer of cellular glutathione and NAD(P)H: qui-none oxidoreductase 1 in PC12 neuronal cells: A potential adaptive mechanism for dopaminergic neuroprotection. Neurochem Res. 33: 2197-2205, 2008..
75. Jia Z, Zhu H, Misra HP, and Li Y. Potent induction of total cellular GSH and NQO1 as well as mitochondrial GSH by 3H-1, 2-dithiole-3-thione in SH-SY5Y neuroblastoma cells and primary human neurons: Protection against neurocy-totoxicity elicited by dopamine, 6-hydroxydopamine, 4-hydroxy-2-nonenal, or hydrogen peroxide. Brain Res 1197: 159-169, 2008..
76. Jocelyn PC. Some properties of mitochondrial glutathione. Biochim Biophys Acta 396: 427-436, 1975..
77. Jocelyn PC and Dickson J. Glutathione and the mitochon-drial reduction of hydroperoxides. Biochim Biophys Acta 590: 1-12, 1980..
78. Johansson C, Lillig CH, and Holmgren A. Human mito-chondrial glutaredoxin reduces S-glutathionylated proteins with high affinity accepting electrons from either glutathi-one or thioredoxin reductase. J Biol Chem 279: 7537-7543, 2004.. (Pubitemid 38294632)
79. Jones DP. Redox potential of GSH/GSSG couple: Assay and biological significance. In: Methods Enzymol. Helmut S, Lester P, eds. Academic Press; 2002. pp. 93-112..
80. Jones DP. Disruption of mitochondrial redox circuitry in oxidative stress. Chem Biol Interact 163: 38-53, 2006.. (Pubitemid 44572221)
81. Jones DP. Redox sensing: Orthogonal control in cell cycle and apoptosis signalling. J Intern Med 268: 432-448, 2010..
82. Jonsson TJ, Murray MS, Johnson LC, Poole LB, and Low-ther WT. Structural basis for the retroreduction of inactivated peroxiredoxins by human sulfiredoxin. Biochemistry 44: 8634-8642, 2005.. (Pubitemid 40840429)
83. Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, Osipov AN, Belikova NA, Kapralov AA, Kini V, Vlasova II, Zhao Q, Zou M, Di P, Svistunenko DA, Kurnikov IV, and Borisenko GG. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 1: 223-232, 2005..
84. Kaneto H, Kawamori D, Matsuoka TA, Kajimoto Y, and Yamasaki Y. Oxidative stress and pancreatic beta-cell dysfunction. Am J Ther 12: 529-533, 2005.. (Pubitemid 41689753)
85. Kanwar M, Chan PS, Kern TS, and Kowluru RA. Oxidative damage in the retinal mitochondria of diabetic mice:: Possible protection by superoxide dismutase. Invest Oph-thalmol Vis Sci 48: 3805-3811, 2007.. (Pubitemid 351261121)
86. Kemp M, Go YM, and Jones DP. Nonequilibrium thermodynamics of thiol/disulfide redox systems: A perspective on redox systems biology. Free Radic Biol Med 44: 921-937, 2008..
87. Kenchappa RS and Ravindranath V. Glutaredoxin is essential for maintenance of brain mitochondrial complex I: Studies with MPTP. FASEB J 17: 717-719, 2003..
88. Kerr JFR, Winterford CM, and Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 73: 2013-2026, 1994.. (Pubitemid 24107952)
89. +- dependent isocitrate dehydrogenase activity by glutathio-nylation. J Biol Chem 280: 10846-10854, 2005..
90. Kim SH, Fountoulakis M, Cairns N, and Lubec G. Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome. J Neural Transm Suppl 61: 223-235, 2001.. (Pubitemid 38085085)
91. Klatt P and Lamas S. Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. Eur J Biochem 267: 4928-4944, 2000.. (Pubitemid 30641289)
92. Krahenbuhl S, Talos C, Lauterburg BH, and Reichen J. Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats. Hepatology 22: 607-612, 1995..
93. Krapfenbauer K, Engidawork E, Cairns N, Fountoulakis M, and Lubec G. Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res 967: 152-160, 2003.. (Pubitemid 36324297)
94. Kroemer G, Dallaporta B, and Resche-Rigon M. The mito-chondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol. 60: 619-642, 1998.. (Pubitemid 28157889)
95. Kropotov A, Gogvadze V, Shupliakov O, Tomilin N, Ser-ikov VB, Tomilin NV, and Zhivotovsky B. Peroxiredoxin V is essential for protection against apoptosis in human lung carcinoma cells. Exp Cell Res 312: 2806-2815, 2006..
96. Lash LH. Mitochondrial glutathione transport: Physiological, pathological and toxicological implications. Chem Biol Interact. 163: 54-67, 2006.. (Pubitemid 44572210)
97. Lee DW, Kaur D, Chinta SJ, Rajagopalan S, and Andersen JK. A disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: Implications for Parkinson's disease. Antioxid Redox Signal 11: 2083-2094, 2009..
98. 2+ release from mitochondria by the oxidation-reduction state of pyridine nucleotides. Proc Natl Acad Sci USA 75: 1690-1694, 1978.. (Pubitemid 8344377)
99. Leist M, Single B, Castoldi AF, Kuhnle S, and Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis. J Exp Med. 185: 1481-1486, 1997.. (Pubitemid 27187604)
100. Li L, Shoji W, Takano H, Nishimura N, Aoki Y, Takahashi R, Goto S, Kaifu T, Takai T, and Obinata M. Increased susceptibility of MER5 (peroxiredoxin III) knockout mice to LPS-induced oxidative stress. Biochem Biophys Res Commun 355: 715-721, 2007.. (Pubitemid 46330210)
101. Lillig CH and Holmgren A. Thioredoxin and related mol-ecules-From biology to health and disease. Antioxid Redox Signal 9: 25-47, 2007.. (Pubitemid 44901873)
102. Lillig CH, Lonn ME, Enoksson M, Fernandes AP, and Holmgren A. Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide. Proc Natl Acad Sci USA 101: 13227-13232, 2004.. (Pubitemid 39209647)
103. Liu X, Kim CN, Yang J, Jemmerson R, and Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157, 1996.. (Pubitemid 26256586)
104. Lluis JM, Colell A, Garcia-Ruiz C, Kaplowitz N, and Fer-nandez-Checa JC. Acetaldehyde impairs mitochondrial glutathione transport in HepG2 cells through endoplasmic reticulum stress. Gastroenterology 124: 708-724, 2003.. (Pubitemid 36268490)
105. Lötscher HR, Winterhalter KH, Carafoli E, and Richter C. Hydroperoxide-induced loss of pyridine nucleotides and release of calcium from rat liver mitochondria. J Biol Chem 255: 9325-9330, 1980..
106. Lowell BB and Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 307: 384-387, 2005.. (Pubitemid 40139974)
107. Maher P. Redox control of neural function: Background, mechanisms, and significance. Antioxid Redox Signal 8: 1941-1970, 2006.. (Pubitemid 46489624)
108. Mari M, Caballero F, Colell A, Morales A, Caballeria J, Fernandez A, Enrich C, Fernandez-Checa JC, and Garcia-Ruiz C. Mitochondrial free cholesterol loading sensitizes to TNF-and Fas-mediated steatohepatitis. Cell Metab 4: 185-198, 2006.. (Pubitemid 44307975)
109. Marí M, Morales A, Colell A, García-Ruiz C, and Fernán-dez-Checa JC. Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal 11: 2685-2700, 2009..
110. Masini A, Ceccarelli D, Trenti T, Gallesi D, and Muscatello U. Mitochondrial inner membrane permeability changes induced by octadecadienoic acid hydroperoxide. Role of mitochondrial GSH pool. Biochim Biophys Acta 1101: 84-89, 1992..
111. Mattson MP and Magnus T. Ageing and neuronal vulnerability. Nat Rev Neurosci 7: 278-294, 2006..
112. McKernan TB, Woods EB, and Lash LH. Uptake of gluta-thione by renal cortical mitochondria. Arch Biochem Biophys 288: 653-663, 1991..
113. Mehendale H, Roth R, Gandolfi A, Klaunig J, Lemasters J, and Curtis L. Novel mechanisms in chemically induced hepatotoxicity. FASEB J 8: 1285-1295, 1994..
114. Meredith MJ and Reed DJ. Depletion in vitro of mitochon-drial glutathione in rat hepatocytes and enhancement of lipid peroxidation by adriamycin and 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Biochem. Pharmacol. 32: 1383-1388, 1983.. (Pubitemid 13088968)
115. Allen EMG and Mieyal JJ. Protein-thiol oxidation and cell death: Regulatory role of glutaredoxins. Antioxid Redox Signal 17: 1748-1763, 2012..
116. Miller EW, Dickinson BC, and Chang CJ. Aquaporin-3 mediates hydrogen peroxide uptake to regulate downstream intracellular signaling. Proc Natl Acad Sci USA 107: 15681-15686., 2010..
117. Miranda-Vizuete A, Damdimopoulos AE, and Spyrou G. The mitochondrial thioredoxin system. Antioxid Redox Signal 2: 801-810, 2000.. (Pubitemid 32063256)
118. Moran LK, Gutteridge JM, and Quinlan GJ. Thiols in cellular redox signalling and control. Curr Med Chem 8: 763-772, 2001.. (Pubitemid 32427905)
119. Mukhopadhyay SS, Leung KS, Hicks MJ, Hastings PJ, Youssoufian H, and Plon SE. Defective mitochondrial per-oxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia. J Cell Biol 175: 225-235, 2006.. (Pubitemid 44631417)
120. Muyderman H, Nilsson M, and Sims NR. Highly selective and prolonged depletion of mitochondrial glutathione in astrocytes markedly increases sensitivity to peroxynitrite. J Neurosci 24: 8019-8028, 2004.. (Pubitemid 39280821)
121. Muyderman H, Wadey AL, Nilsson M, and Sims NR. Mi-tochondrial glutathione protects against cell death induced by oxidative and nitrative stress in astrocytes. J Neurochem 102: 1369-1382, 2007.. (Pubitemid 47174244)
122. Nagy N, Malik G, Tosaki A, Ho YS, Maulik N, and Das DK. Overexpression of glutaredoxin-2 reduces myocardial cell death by preventing both apoptosis and necrosis. J Mol Cell Cardiol 44: 252-60, 2008..
123. Nalvarte I, Damdimopoulos AE, and Spyrou G. Human mitochondrial thioredoxin reductase reduces cytochrome c and confers resistance to complex III inhibition. Free Radic Biol Med 36: 1270-1278, 2004.. (Pubitemid 38526321)
124. Naoi M, Maruyama W, Yi H, Yamaoka Y, Shamoto-Nagai M, Akao Y, Gerlach M, Tanaka M, and Riederer P. Neu-romelanin selectively induces apoptosis in dopaminergic SH-SY5Y cells by deglutathionylation in mitochondria: Involvement of the protein and melanin component. J Neu-rochem 105: 2489-2500, 2008.. (Pubitemid 351782270)
125. Navarro A and Boveris A. The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol 292: C670-686, 2007..
126. Navarro A and Boveris A. Mitochondrial nitric oxide syn-thase, mitochondrial brain dysfunction in aging, and mitochondria-targeted antioxidants. Adv Drug Deliv Rev 60: 1534-1544, 2008..
127. Noctor G, Arisi A-CM, Jouanin L, Kunert KJ, Rennenberg H, and Foyer CH. Glutathione: Biosynthesis, metabolism and relationship to stress tolerance explored in transformed plants. J Exp Bot 49: 623-647, 1998.. (Pubitemid 28203034)
128. Noh DY, Ahn SJ, Lee RA, Kim SW, Park IA, and Chae HZ. Overexpression of peroxiredoxin in human breast cancer. Anticancer Res 21: 2085-2090, 2001..
129. Noh YH, Baek JY, Jeong W, Rhee SG, and Chang TS. Sul-firedoxin translocation into mitochondria plays a crucial role in reducing hyperoxidized peroxiredoxin III. J Biol Chem 284: 8470-8477, 2009..
130. Nonn L, Berggren M, and Powis G. Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. Mol Cancer Res 1: 682-689, 2003.. (Pubitemid 36870521)
131. Nonn L, Williams RR, Erickson RP, and Powis G. The absence of mitochondrial thioredoxin 2 causes massive apo-ptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol Cell Biol 23: 916-922, 2003.. (Pubitemid 36133510)
132. Nulton-Persson AC, Starke DW, Mieyal JJ, and Szweda LI. Reversible inactivation of alpha-ketoglutarate dehydroge-nase in response to alterations in the mitochondrial gluta-thione status. Biochemistry 42: 4235-4242, 2003.. (Pubitemid 36418317)
133. Olmos Y, Valle I, Borniquel S, Tierrez A, Soria E, Lamas S, and Monsalve M. Mutual dependence of Foxo3a and PGC-1alpha in the induction of oxidative stress genes. J Biol Chem 284: 14476-14484, 2009..
134. Ott M, Robertson JD, Gogvadze V, Zhivotovsky B, and Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci USA 99: 1259-1263, 2002.. (Pubitemid 34136480)
135. Pacher P, Beckman JS, Liaudet L. Nitric oxide and per-oxynitrite in health and disease. Physiol Rev 87: 315-424, 2007.. (Pubitemid 46217686)
136. Pai HV, Starke DW, Lesnefsky EJ, Hoppel CL, and Mieyal JJ. What is the functional significance of the unique location of glutaredoxin 1 (GRx1) in the intermembrane space of mitochondria? Antioxid Redox Signal 9: 2027-2033, 2007.. (Pubitemid 47622345)
137. Papadia S, Soriano FX, Leveille F, Martel MA, Dakin KA, Hansen HH, Kaindl A, Sifringer M, Fowler J, Stefovska V, McKenzie G, Craigon M, Corriveau R, Ghazal P, Hors-burgh K, Yankner BA, Wyllie DJ, Ikonomidou C, and Hardingham GE. Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci 11: 476-487, 2008.. (Pubitemid 351441886)
138. Peng Y, Yang PH, Guo Y, Ng SS, Liu J, Fung PC, Tay D, Ge J, He ML, Kung HF, and Lin MC. Catalase and peroxir-edoxin 5 protect Xenopus embryos against alcohol-induced ocular anomalies. Invest Ophthalmol Vis Sci 45: 23-29, 2004.. (Pubitemid 38055663)
139. Perez VI, Lew CM, Cortez LA, Webb CR, Rodriguez M, Liu Y, Qi W, Li Y, Chaudhuri A, Van Remmen H, Richardson A, and Ikeno Y. Thioredoxin 2 haploinsuffi-ciency in mice results in impaired mitochondrial function and increased oxidative stress. Free Radic Biol Med 44: 882-892, 2008..
140. Planson AG, Palais G, Abbas K, Gerard M, Couvelard L, Delaunay A, Baulande S, Drapier JC, and Toledano MB. Sulfiredoxin protects mice from lipopolysaccharide-induced endotoxic shock. Antioxid Redox Signal 14: 2071-2080, 2011..
141. Poderoso JJ. The formation of peroxynitrite in the applied physiology of mitochondrial nitric oxide. Arch Biochem Biophys 484: 214-220, 2009..
142. Powis G, Montfort WR. Properties and biological activities of thioredoxins. Annu Rev Biophys Biomol Struct 30: 421-455, 2001.. (Pubitemid 32566170)
143. Precht TA, Phelps RA, Linseman DA, Butts BD, Le SS, Laessig TA, Bouchard RJ, Heidenreich KA. The permeability transition pore triggers Bax translocation to mitochondria during neuronal apoptosis. Cell Death Differ 12: 255-265, 2005.. (Pubitemid 40360949)
144. Queiroga CS, Almeida AS, Martel C, Brenner C, Alves PM, and Vieira HL. Glutathionylation of adenine nucleotide translocase induced by carbon monoxide prevents mito-chondrial membrane permeabilization and apoptosis. J Biol Chem 285: 17077-17088, 2010..
145. Radyuk SN, Michalak K, Klichko VI, Benes J, Rebrin I, Sohal RS, and Orr WC. Peroxiredoxin 5 confers protection against oxidative stress and apoptosis and also promotes longevity in Drosophila. Biochem J 419: 437-445, 2009..
146. Reed DJ. Glutathione: Toxicological implications. Annu Rev Pharmacol Toxicol. 30: 603-631, 1990..
147. Rhee SG, Chae HZ, and Kim K. Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38: 1543-1552, 2005.. (Pubitemid 40726061)
148. Rhee SG, Jeong W, Chang TS, and Woo HA. Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys per-oxiredoxin: Its discovery, mechanism of action, and biological significance. Kidney Int Suppl 106: S3-8, 2007..
149. Rhee SG and Woo HA. Multiple functions of peroxir-edoxins: Peroxidases, sensors and regulators of the intra-cellular messenger HO, and protein chaperones. Antioxid Redox Signal 15: 781-794, 2011..
150. Richter C, Schweizer M, Cossarizza A, and Franceschi C. Control of apoptosis by the cellular ATP level. FEBS Lett 378: 107-110, 1996.. (Pubitemid 26015556)
151. Rohrbach S, Gruenler S, Teschner M, and Holtz J. The thioredoxin system in aging muscle: Key role of mito-chondrial thioredoxin reductase in the protective effects of caloric restriction? Am J Physiol Regul Integr Comp Physiol 291: R927-935, 2006..
152. Roussel X, Boukhenouna S, Rahuel-Clermont S, and Branlant G. The rate-limiting step of sulfiredoxin is associated with the transfer of the gamma-phosphate of ATP to the sulfinic acid of overoxidized typical 2-Cys peroxiredoxins. FEBS Lett 585: 574-578, 2011..
153. Rydstrom J. Mitochondrial NADPH, transhydrogenase, and disease. Biochim Biophys Acta 1757: 721-726., 2006..
154. Saeed U, Durgadoss L, Valli RK, Joshi DC, Joshi PG, and Ravindranath V. Knockdown of cytosolic glutaredoxin 1 leads to loss of mitochondrial membrane potential: Implication in neurodegenerative diseases. PLoS One 3: e2459, 2008..
155. Saxena G, Chen J, and Shalev A. Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein. J Biol Chem 285: 3997-4005, 2010..
156. Seo MS, Kang SW, Kim K, Baines IC, Lee TH, and Rhee SG. Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J Biol Chem 275: 20346-20354, 2000.. (Pubitemid 30457609)
157. Shan X, Jones DP, Hashmi M, and Anders MW. Selective depletion of mitochondrial glutathione concentrations by (R, S)-3-hydroxy-4-pentenoate potentiates oxidative cell death. Chem Res Toxicol. 6: 75-81, 1993.. (Pubitemid 23040376)
158. Sheeran FL, Rydstrom J, Shakhparonov MI, Pestov NB, and Pepe S. Diminished NADPH transhydrogenase activity and mitochondrial redox regulation in human failing myocardium. Biochim Biophys Acta 1797: 1138-1148, 2010..
159. Sibbing D, Pfeufer A, Perisic T, Mannes AM, Fritz-Wolf K, Unwin S, Sinner MF, Gieger C, Gloeckner CJ, Wichmann HE, Kremmer E, Schafer Z, Walch A, Hinterseer M, Na-bauer M, Kaab S, Kastrati A, Schomig A, Meitinger T, Bornkamm GW, Conrad M, and von Beckerath N. Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy. Eur Heart J 32: 1121-1133, 2011..
160. Sies H and Moss K. A role of mitochondrial glutathione peroxidase in modulating mitochondrial oxidations in liver. Eur J Biochem 84: 377-383, 1978.. (Pubitemid 8301267)
161. Simonian NA and Coyle JT. Oxidative stress in neurode-generative diseases. Annu Rev Pharmacol Toxicol 36: 83-106, 1996..
162. Sims NR and Anderson MF. Mitochondrial contributions to tissue damage in stroke. Neurochem Int 40: 511-526, 2002.. (Pubitemid 34159152)
163. Singh A, Ling G, Suhasini AN, Zhang P, Yamamoto M, Navas-Acien A, Cosgrove G, Tuder RM, Kensler TW, Watson WH, and Biswal S. Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxi-dative stress in lungs. Free Radic Biol Med 46: 376-386, 2009..
164. + in Drosophila melanogaster. Mech Ageing Dev 56: 223-235, 1990..
165. Sohal RS and Dubey A. Mitochondrial oxidative damage, hydrogen peroxide release, and aging. Free Radic Biol Med 16: 621-626, 1994..
166. Spyrou G, Enmark E, Miranda-Vizuete A, and Gustafsson J. Cloning and expression of a novel mammalian thior-edoxin. J Biol Chem 272: 2936-2941, 1997.. (Pubitemid 27053344)
167. Svoboda DJ and Manning RT. Chronic alcoholism with fatty metamorphosis of the liver. Mitochondrial alterations in hepatic cells. Am J Pathol 44: 645-662, 1964..
168. Tanaka T, Hosoi F, Yamaguchi-Iwai Y, Nakamura H, Ma-sutani H, Ueda S, Nishiyama A, Takeda S, Wada H, Spyrou G, Yodoi J. Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J 21: 1695-1703, 2002.. (Pubitemid 34614625)
169. Taylor ER, Hurrell F, Shannon RJ, Lin TK, Hirst J, and Murphy MP. Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J Biol Chem 278: 19603-19610, 2003.. (Pubitemid 36799143)
170. Terada LS. Specificity in reactive oxidant signaling: Think globally, act locally. J Cell Biol 174: 615-623., 2006..
171. Thompson C. Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995..
172. Trujillo M, Clippe A, Manta B, Ferrer-Sueta G, Smeets A, Declercq JP, Knoops B, and Radi R. Pre-steady state kinetic characterization of human peroxiredoxin 5: Taking advantage of Trp84 fluorescence increase upon oxidation. Arch Biochem Biophys 467: 95-106, 2007.. (Pubitemid 47625297)
173. Tsujimoto Y, Nakagawa T, and Shimizu S. Mitochondrial membrane permeability transition and cell death. Biochim Biophys Acta 1757: 1297-1300, 2006.. (Pubitemid 44442106)
174. Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M, and Yodoi J. Redox control of cell death. Antioxid Redox Signal 4: 405-414, 2002.. (Pubitemid 34753380)
175. Valdez LB, Zaobornyj T, and Boveris A. Mitochondrial metabolic states and membrane potential modulate mtNOS activity. Biochim Biophys Acta 1757: 166-172, 2006..
176. Van Remmen H and Jones DP. Current thoughts on the role of mitochondria and free radicals in the biology of aging. J Gerontol A Biol Sci Med Sci 64: 171-174, 2009..
177. Veal E and Day A. Hydrogen peroxide as a signaling molecule. Antioxid Redox Signal 15: 147-151., 2011..
178. Vendemiale G, Grattagliano I, Altomare E, Turturro N, and Guerrieri F. Effect of acetaminophen administration on hepatic glutathione compartmentation and mitochondrial energy metabolism in the rat. Biochem Pharmacol 52: 1147-1154, 1996.. (Pubitemid 26355290)
179. Venkatakrishnan P, Nakayasu ES, Almeida IC, and Miller RT. Absence of nitric-oxide synthase in sequentially purified rat liver mitochondria. J Biol Chem 284: 19843-19855, 2009..
180. Vina J, Sastre J, Anton V, Bruseghini L, Esteras A, and Asensi M. Effect of aging on glutathione metabolism. Protection by antioxidants. EXS 62: 136-144, 1992..
181. Wang D, Masutani H, Oka S, Tanaka T, Yamaguchi-Iwai Y, Nakamura H, and Yodoi J. Control of mitochondrial outer membrane permeabilization and Bcl-xL levels by thior-edoxin 2 in DT40 cells. J Biol Chem 281: 7384-7391, 2006.. (Pubitemid 43847508)
182. Wei Q, Jiang H, Matthews CP, and Colburn NH. Sulfir-edoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies. Proc Natl Acad Sci USA 105: 19738-19743, 2008..
183. Weil M, Jacobson MD, Coles HS, Davies TJ, Gardner RL, Raff KD, and Raff MC. Constitutive expression of the machinery for programmed cell death. J Cell Biol 133: 1053-1059, 1996.. (Pubitemid 26172510)
184. Wenzel P, Hink U, Oelze M, Schuppan S, Schaeuble K, Schildknecht S, Ho KK, Weiner H, Bachschmid M, Munzel T, and Daiber A. Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity. Implications for mitochondrial oxida-tive stress and nitrate tolerance. J Biol Chem 282: 792-799, 2007.. (Pubitemid 47076617)
185. West MB, Hill BG, Xuan YT, and Bhatnagar A. Protein glutathiolation by nitric oxide: An intracellular mechanism regulating redox protein modification. FASEB J 20: 1715-1717, 2006..
186. Wilkins HM, Marquardt K, Lash LH, and Linseman DA. Bcl-2 is a novel interacting partner for the 2-oxoglutarate carrier and a key regulator of mitochondrial glutathione. Free Radic Biol Med 52: 410-419, 2012..
187. Wonsey DR, Zeller KI, and Dang CV. The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation. Proc Natl Acad Sci USA 99: 6649-6654, 2002.. (Pubitemid 34526187)
188. Woo HA, Chae HZ, Hwang SC, Yang KS, Kang SW, Kim K, and Rhee SG. Reversing the inactivation of peroxir-edoxins caused by cysteine sulfinic acid formation. Science 300: 653-656, 2003.. (Pubitemid 36520592)
189. Woo HA, Jeong W, Chang TS, Park KJ, Park SJ, Yang JS, and Rhee SG. Reduction of cysteine sulfinic acid by sulfir-edoxin is specific to 2-cys peroxiredoxins. J Biol Chem 280: 3125-3128, 2005.. (Pubitemid 40223772)
190. 2 accumulation for cell signaling. Cell 140: 517-528, 2010..
191. Wood-Allum CA, Barber SC, Kirby J, Heath P, Holden H, Mead R, Higginbottom A, Allen S, Beaujeux T, Alexson SE, Ince PG, and Shaw PJ. Impairment of mitochondrial anti-oxidant defence in SOD1-related motor neuron injury and amelioration by ebselen. Brain 129: 1693-1709, 2006.. (Pubitemid 43999404)
192. Wood ZA, Poole LB, and Karplus PA. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300: 650-653, 2003.. (Pubitemid 36520591)
193. Wood ZA, Schroder E, Robin Harris J, and Poole LB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 28: 32-40, 2003.. (Pubitemid 36051004)
194. Wü llner U, Seyfried J, Groscurth P, Beinroth S, Winter S, Gleichmann M, Heneka M, Löschmann PA, Schulz JB, Weller M, and Klockgether T. Glutathione depletion and neuronal cell death: The role of reactive oxygen intermediates and mitochondrial function. Brain Res 826: 53-62, 1999.. (Pubitemid 29222959)
195. Yin F, Sancheti H, and Cadenas E. Silencing of nicotin-amide nucleotide transhydrogenase impairs cellular redox homeostasis and energy metabolism in PC12 cells. Biochim Biophys Acta 1817: 401-409, 2012..
196. +/NADPH in cellular functions and cell death: Regulation and biological consequences. Antioxid Redox Signal 10: 179-206, 2008..
197. Zhang D, Lu C, Whiteman M, Chance B, and Armstrong JS. The mitochondrial permeability transition regulates cyto-chrome c release for apoptosis during endoplasmic reticu-lum stress by remodeling the cristae junction. J Biol Chem 283: 3476-3486, 2008..
198. Zhang H, Go YM, and Jones DP. Mitochondrial thior-edoxin-2/peroxiredoxin- 3 system functions in parallel with mitochondrial GSH system in protection against oxidative stress. Arch Biochem Biophys 465: 119-126, 2007.. (Pubitemid 47283985)
199. Zhang R, Al-Lamki R, Bai L, Streb JW, Miano JM, Bradley J, and Min W. Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner. Circ Res 94: 1483-1491, 2004.. (Pubitemid 38780321)
200. Zhao P, Kalhorn TF, and Slattery JT. Selective mitochon-drial glutathione depletion by ethanol enhances acetaminophen toxicity in rat liver. Hepatology 36: 326-335, 2002.. (Pubitemid 34810351)
201. Zhao P and Slattery JT. Effects of ethanol dose and ethanol withdrawal on rat liver mitochondrial glutathione: Implication of potentiated acetaminophen toxicity in alcoholics. Drug Metab Dispos. 30: 1413-1417, 2002.. (Pubitemid 35397047)
202. Zheng LM, Zychlinsky A, Liu CC, Ojcius DM, and Young JD. Extracellular ATP as a trigger for apoptosis or programmed cell death. J Cell Biol 112: 279-288, 1991.. (Pubitemid 21909618)
203. Zhong Q, Putt DA, Xu F, and Lash LH. Hepatic mito-chondrial transport of glutathione: Studies in isolated rat liver mitochondria and H4IIE rat hepatoma cells. Arch Biochem Biophys 474: 119-127, 2008..
204. Zhou Y, Kok KH, Chun AC, Wong CM, Wu HW, Lin MC, Fung PC, Kung H, and Jin DY. Mouse peroxiredoxin V is a thioredoxin peroxidase that inhibits p53-induced apoptosis. Biochem Biophys Res Commun 268: 921-927, 2000.. (Pubitemid 30150892)
205. Zimmermann AK, Loucks FA, Schroeder EK, Bouchard RJ, Tyler KL, and Linseman DA. Glutathione binding to the Bcl-2 homology-3 domain groove: A molecular basis for Bcl-2 antioxidant function at mitochondria. J Biol Chem 282: 29296-29304, 2007.. (Pubitemid 350043369)